The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC.
 
Helena Bote
No Relationships to Disclose
 
Marco Siringo
No Relationships to Disclose
 
Esther García-Lorenzo
No Relationships to Disclose
 
Alicia Castelo
Speakers' Bureau - AstraZeneca Spain; Sanofi
Travel, Accommodations, Expenses - Ipsen; Pierre Fabre
 
Esther Conde
Honoraria - AstraZeneca; Lilly O.; Pfizer; Roche
Research Funding - Roche; Thermofisher Scientific Biomarkers
 
Susana Hernández
Honoraria - AstraZeneca; Lilly O.; Pfizer; Roche
Research Funding - Lilly O.; Roche; Thermo Fisher Scientific
 
Mercedes Herrera
Honoraria - AstraZeneca Spain
 
Yolanda Ruano-Domínguez
No Relationships to Disclose
 
Javier Baena
Honoraria - AstraZeneca Spain; AstraZeneca Spain; Bristol-Myers Squibb/Pfizer
Consulting or Advisory Role - AstraZeneca Spain; Roche; Roche
Expert Testimony - Roche
Travel, Accommodations, Expenses - MSD; MSD
 
Ana Belén Enguita
No Relationships to Disclose
 
Fernando Lopez-Rios Moreno
Honoraria - AstraZeneca; Bayer; BMS; Janssen; Lilly; MSD; Pfizer; Roche; Takeda; Thermo Fisher Scientific
Research Funding - Lilly; Roche; Thermo Fisher Scientific
 
Jon Zugazagoitia
Honoraria - AstraZeneca Spain; Bristol-Myers Squibb/Celgene; Guardant Health; NanoString Technologies; Pfizer; Roche/Genentech; Sanofi/Regeneron
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; Novartis; Novartis; Pfizer; Sanofi/Regeneron
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; MSD Oncology; NanoString Technologies; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Roche/Genentech
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Janssen; Lilly; Medscape; Merck Serono; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Regeneron; Roche/Genentech; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); Pfizer (Inst); PharmaMar (Inst)
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)